Safety and effectiveness of Belantamab Mafodotin for Multiple Myeloma using the Flatiron Health Database

Trial description: This study evaluates the real-world use, safety and effectiveness of belantamab mafodotin.The index date is defined as the date of the first observed administration of belantamab mafodotin.The post-index period spans from the index date until the end of follow-up (defined as the start of participation in an interventional clinical trial, end of clinical activity, end of data availability, or death; whichever comes first).The post-index treatment period is defined as the duration of the belantamab mafodotin line of treatment. This spans from the index date until the permanent discontinuation of belantamab mafodotin treatment,the confirmed date of a new line of treatment, or the end of follow-up; whichever comes first.